San Francisco, 27 March, Biopharmaceutical Third Party Logistics (3PL)
Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain,
Non-cold Chain), By Service, By Region, And Segment Forecasts, 2019 – 2025
The global biopharmaceutical third party logistics market size is expected to reach USD 120.64 billion by
2025, at a CAGR 4.9% over the forecast period, according to a new report by
Grand View Research, Inc. The market for biopharmaceutical third party
logistics (3PL) is majorly driven by rising demand for temperature controlled
logistic services to transport biologics in various regions and growing
distribution networks of biopharmaceutical companies to improve their sales.
Rising adoption of automated storage and retrieval systems in the emerging
countries is an ongoing trend in the pharmaceutical logistics companies that
has gained a significant traction.
Furthermore,
the trend of shifting from small molecule drugs to biopharmaceuticals, mainly
vaccines and biologics, is projected to drive the market. Since, these small
molecule drugs are temperature sensitive products, demand for temperature
controlled transportation and storage increases and thus is responsible for the
market growth. As of now, the pharmaceutical sales through distributors have
grown from USD 304.6 billion in 2013 to USD 440.2 billion in 2016. However, the
average number of manufacturers per distributor had declined from 1,474 in 2014
to 1,211 in 2016. This data depicts that there is an increase in quantity of
pharmaceutical products being distributed, and thus, is expected to surge the
demand for 3PL services.
Additionally,
environmental concerns and cost have caused a slight shift in the means of
transport used for commercial product, moving from airway to seaway shipping
and in roadways from truck to intermodal (both rail and truck). The intermodal
transport is majorly used by these pharmaceutical companies to reduce the
carbon footprint. The ongoing trend shows that the pharmaceutical manufacturers
have shifted towards sea freight to reduce the cost and risk factor. Although
for cold chain products, the companies still prefer air freight. However, some
of the large pharmaceutical companies are planning to transport 70% of their
products via ocean freight including cold chain products.
Access Full
Research Report On Biopharmaceutical Third Party Logistics (3PL)
Market Analysis:
Further key findings from the report
suggest:
·
In 2018, non-cold chain
logistics held the largest market share in terms of revenue owing to the sales
of a large number of drugs that do not require any temperature control
·
Cold chain logistics segment is
expected to register the faster CAGR over the forecast period owing to the
demand for biologics, such as cellular therapies, vaccines, and test kits
·
Warehousing and storage held
the largest market share among the types of services in 2018
·
Asia pacific expected to emerge
with the fastest CAGR over the forecast period owing to adoption of medicines
from aging population and shift of drug sales from brand manufacturers to
generic
·
Key players operating in the
biopharmaceutical third party logistics market include DHL International GmbH.,
SF Express, United Parcel Service of America, Inc, AmerisourceBergen
Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and
Agility
Browse More Reports Of This
Category By Grand View Research At: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the global biopharmaceutical third party logistics market on the
basis of service, participant, and region:
Biopharmaceutical
Third Party Logistics Supply Chain Outlook (Revenue, USD Million, 2014 -
2025)
·
Cold Chain
·
Non-cold Chain
Biopharmaceutical
Third Party Logistics Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Transportation
o
Air Freight
o
Sea Freight
o
Overland
·
Warehousing and Storage
·
Others
Biopharmaceutical
Third Party Logistics Regional Outlook (Revenue, USD Million, 2014 -
2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
o
France
o
Italy
o
Spain
·
Asia Pacific
o
China
o
Japan
o
India
o
Australia
o
New Zealand
·
Latin America
o
Brazil
o
Mexico
o
Argentina
·
Middle East & Africa
o
South Africa
o
Saudi Arabia
o
UAE
Access Full
Press Release of this Report: https://www.grandviewresearch.com/press-release/global-biopharmaceutical-third-party-logistics-3pl-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment